Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms

This study has been completed.

Study NCT00079989 Information provided by Wyeth is now a wholly owned subsidiary of Pfizer

First Received: March 19, 2004 Last Updated: October 9, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given